COVID-19 Research

Ayass BioScience, LLC working to find ways to better understand, treat and eventually eliminate COVID-19 and the illness that results from infection

Research of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has been a significant focus of scientific investigation in our company. Our scientists have been studying various aspects of the virus, including its origin, transmission, pathogenesis, diagnostics, and therapeutics.

Research has been conducted to explore potential treatments for COVID-19. We developed SARS-CoV-2 aptamers that are S-Protein specific and may be a specific therapeutic agent for COVID-19 therapy.

SARS-CoV-2 Aptamers Development

Our Published Papers:

Macrophage-Induced Exacerbation of Nasopharyngeal Inflammatory Lymphocytes in COVID-19 Disease(COVID/MDPI)

High-Affinity Neutralizing DNA Aptamers against SARS-CoV-2 Spike Protein Variants (COVID/MDPI)

Therapeutic Aptamer for COVID-19 Management (Virology Journal)

Prediction of Covid-19 Patient’s Outcome from Nasopharyngeal Samples (PLOS ONE)